Galapagos in alliance with Merck in obesity and diabetes

Galapagos NV of Belgium has entered into a multi-year global alliance with Merck & Co. Inc valued at more than €170 million to develop new therapies in obesity and diabetes. The deal was announced on 9 January 2009.